- Trials with a EudraCT protocol (464)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
464 result(s) found for: Nutrition Therapy.
Displaying page 1 of 24.
EudraCT Number: 2016-004978-17 | Sponsor Protocol Number: FAR-NP-2017-01 | Start Date*: 2017-07-27 | ||||||||||||||||||||||||||
Sponsor Name:Hospital Universitari Bellvitge | ||||||||||||||||||||||||||||
Full Title: CLINICAL, RANDOMIZED, DOUBLE LIND CLINICAL TRIAL TO STUDY THE EFFECT OF PARENTERAL SUPPLEMENTATION WITH FISH OIL EMULSION IN THE NUTRITIONAL SUPPORT IN ESOPHAGECTOMIZED PATIENTS | ||||||||||||||||||||||||||||
Medical condition: Esophagectomy due to esophageal neoplasia | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001509-28 | Sponsor Protocol Number: INS-PI-TO | Start Date*: 2012-03-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA | |||||||||||||
Full Title: Efficacy and mechanisms of a short course of intensified insulin treatment on remission or responsiveness to oral therapy in type 2 diabetes | |||||||||||||
Medical condition: Newly-diagnosed type 2 diabetes patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009918-40 | Sponsor Protocol Number: LG-TAU-2008-04 | Start Date*: 2009-07-22 | |||||||||||
Sponsor Name:LABORATORIOS GRIFOLS, S.A. | |||||||||||||
Full Title: Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pa... | |||||||||||||
Medical condition: Evaluar el efecto de la taurina en nutrición Parenteral Total sobre la función hepática en pacientes postquirúrgicos. Evaluate the effect of taurine in Total Parenteral Nutrition on the hepatic fun... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003614-27 | Sponsor Protocol Number: GIA-DAP-16-005 | Start Date*: 2017-08-16 | |||||||||||
Sponsor Name:UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI | |||||||||||||
Full Title: Study on the effect of dapagliflozin on myocardial insulin sensitivity and perfusion (DapaHeart) | |||||||||||||
Medical condition: TYPE 2 DIABETES | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001845-15 | Sponsor Protocol Number: TINCRBEL_study | Start Date*: 2018-07-13 |
Sponsor Name:Academic medical centre, department of internal medicine | ||
Full Title: EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study) | ||
Medical condition: Chronic intestinal failuyre (IF) is caused by large surgical bowel resection, severe motility, or absorption diseorders. These patientds require partial or total parenteral nutrition (PN and TPN, r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004291-20 | Sponsor Protocol Number: 1/05 | Start Date*: 2006-06-08 |
Sponsor Name:Prof.Dr.Hartmut ZWICK | ||
Full Title: Studie zur Wirksamkeit von hyperkalorischer Ernährung und Androgengabe auf die körperliche Leistungsfähigkeit und Lebensqualität von Patienten mit schwerer COPD | ||
Medical condition: Evaluation of the effects of testosteronundecanoat and hypercaloric nutrition in addition to rehabilitative training for patients with severe and very severe COPD | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003397-82 | Sponsor Protocol Number: HC-G-H-0813 | Start Date*: 2012-12-12 | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: Prospective, randomized, controlled, double-blind, parallel-group, mono-centre, explorative Phase IV trial on the efficacy and safety of a fish oil containing lipid emulsion versus a standard soybe... | |||||||||||||
Medical condition: Acute Lung Injury as a result of proven pneumonia (x-ray) or witnessed aspiration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004946-41 | Sponsor Protocol Number: SP-PP18 | Start Date*: 2019-09-12 |
Sponsor Name:Dr. Virgilio P. Carnielli, | ||
Full Title: Personalized versus standard parenteral nutrition for preterm infants with a birth weight greater than 1250 grams: a phase IV randomized clinical trial | ||
Medical condition: Growth of preterm infants with a birth weight greater than 1250g on parenteral nutrition. | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001542-18 | Sponsor Protocol Number: AAD-EU2012 | Start Date*: 2012-07-12 | |||||||||||
Sponsor Name:DuPont Nutrition and Health Active Nutrition | |||||||||||||
Full Title: Effect of a probiotic formula on reducing the risk for antibiotic-associated diarrhea | |||||||||||||
Medical condition: Antibiotic-associated diarrhea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002603-17 | Sponsor Protocol Number: 1218.89 | Start Date*: 2013-01-14 | |||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | |||||||||||||
Full Title: A phase IIIb, multicenter, multinational, randomized, double-blind, placebo controlled, parallel group study to evaluate the glycemic and renal efficacy of once daily administration of linagliptin ... | |||||||||||||
Medical condition: Type 2 diabetes patients receiving treatment with ACEi or ARB with micro- or macroalbuminuria (UACR between 30 and 3000 mg/g creatinine). [ACEi=Angiotensin Converting Enzyme inhibitor; ARB=Angioten... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) FI (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022815-21 | Sponsor Protocol Number: FARM87JEA3 | Start Date*: 2010-12-16 | ||||||||||||||||||||||||||
Sponsor Name:UNIVERSITA` DI TORINO | ||||||||||||||||||||||||||||
Full Title: Use of metformin in obese adolescent patients | ||||||||||||||||||||||||||||
Medical condition: Obesity | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002880-42 | Sponsor Protocol Number: LAL-CL05 | Start Date*: 2011-12-05 | |||||||||||||||||||||
Sponsor Name:Synageva Biopharma Corp. | |||||||||||||||||||||||
Full Title: An Open Label Multicenter Extension Study to Evaluate the Long-Term Efficacy and Safety of SBC 102 in Children with Lysosomal Acid Lipase Deficiency Who Previously Received Treatment with SBC-102 | |||||||||||||||||||||||
Medical condition: Growth failure in children due to lysosomal acid lipase deficiency (Wolman disease). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) FR (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000032-28 | Sponsor Protocol Number: LAL-CL03 | Start Date*: 2011-04-18 | |||||||||||||||||||||
Sponsor Name:Synageva Biopharma Corp. | |||||||||||||||||||||||
Full Title: An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 in Children with Growth Failure Due to Lysosomal ... | |||||||||||||||||||||||
Medical condition: Growth failure in children due to lysosomal acid lipase deficiency (Wolman disease). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) FR (Completed) DE (Prematurely Ended) IT (Completed) IE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-001559-30 | Sponsor Protocol Number: SMKV-013-CP4 | Start Date*: 2017-09-13 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Efficacy of long-term parenteral nutrition with SmofKabiven® E concomitant to chemo- and/or immunotherapy: A prospective, randomised, controlled, open, multicentre, two-stage, adaptive clinical tri... | |||||||||||||
Medical condition: Metastatic Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000044-71 | Sponsor Protocol Number: V3Aug2008 | Start Date*: 2006-10-02 |
Sponsor Name:University Hospitals of Leicester NHS Trust Research & Development Department | ||
Full Title: Randomised controlled trial of the effects of fish oil emulsion in total parenteral nutrition upon tumour vascularity in patients with hepatic colorectal metastases | ||
Medical condition: Potentially resectable hepatic (liver) metastases from colorectal (bowel) cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002126-20 | Sponsor Protocol Number: PID13341 | Start Date*: 2018-08-13 | ||||||||||||||||
Sponsor Name:University of Oxford | ||||||||||||||||||
Full Title: Interleukin-2 therapy of Autoimmunity in Diabetes: ITAD | ||||||||||||||||||
Medical condition: Type 1 Diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000239-28 | Sponsor Protocol Number: D1693C00001 | Start Date*: 2013-07-15 | ||||||||||||||||
Sponsor Name:AstraZeneca AB | ||||||||||||||||||
Full Title: DECLARE Dapagliflozin Effect on CardiovascuLAR Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence o... | ||||||||||||||||||
Medical condition: Type 2 Diabetes mellitus | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) CZ (Completed) IT (Completed) SE (Completed) SK (Completed) BG (Completed) NL (Completed) ES (Completed) DE (Completed) PL (Completed) HU (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003274-32 | Sponsor Protocol Number: 2015/233 | Start Date*: 2016-07-13 |
Sponsor Name:Dra Maria Luz Couce [...] | ||
Full Title: Effect of caffeine citrate in acute bronchiolitis symptoms of apnea in neonates and infants during the first three months of life | ||
Medical condition: Children under 3 years with acute RSV bronchiolitis which present breaks apnea | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000832-82 | Sponsor Protocol Number: GLYCEMIA-Heart | Start Date*: 2018-09-13 | |||||||||||||||||||||
Sponsor Name:FONDAZIONE TOSCANA GABRIELE MONASTERIO | |||||||||||||||||||||||
Full Title: GLYcemic Control with EMpagliflozin vs standard of care in patients with type 2 dIAbetes and Heart failure: effects on cardiac remodeling and neurohormonal activation | |||||||||||||||||||||||
Medical condition: Heart failure and type 2 diabetes mellitus | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002898-19 | Sponsor Protocol Number: IndiviStat#1 | Start Date*: 2018-01-08 |
Sponsor Name:Helsinki University Central Hospital | ||
Full Title: There is no English name for the trial. | ||
Medical condition: Primary prevention of atherosclerotic disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.